US employers split on dropping GLP-1 weight-loss coverage for 2027
Start here
As 2027 approaches, no reliable tally exists of how many US insurance plans will continue covering GLP-1 weight-loss drugs. Discussion among patients and industry observers highlights wide variation: one poster reports their employer will drop weight-loss coverage on January 1, 2027 while keeping diabetes coverage. Self-insured employers set their own formulary rules, so decisions differ plan by plan; some are retaining GLP-1 coverage but adding eligibility requirements, and one union contract guarantees coverage through 2029. Claims of industry-wide removal or 2027 price cuts circulating in the discussion remain unverified user speculation. What is settled is that coverage for 2027 will be fragmented rather than uniform, with the true extent of drop-offs still unknown.
Written by a model from the reports · updated 2 hours ago
Coverage timeline
Follow the coverage to see the different angles.
- reddit.comHow many insurance plans actually KEEPING coverage for 2027?
There is no clear count of how many insurance plans will still cover GLP-1 drugs for weight loss in 2027. A poster says their employer will drop coverage for the weight-loss indication on January 1, 2027, keeping only diabetes coverage. Commenters note that self-insured employers decide formulary coverage themselves, some plans retain GLP-1s but add eligibility requirements, and one union contract guarantees coverage through 2029; claims of industry-wide removal and 2027 price cuts remain user speculation.
Heat trend for this story
Not enough continuous observation yet to draw a trend.